CLOSING DATE: 27 TH SEPTEMBER 2013

Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn POSITION: EXECUTIVE DIRECTOR, IRISH INSTITUTE OF PHARMACY CLOSING DATE: 27 TH SEPTEMBER 2013 EDUCATIONAL EXCELLENCE IN SURGERY MEDICINE PHARMACY PHYSIOTHERAPY NURSING & MIDWIFERY RESEARCH LEADERSHIP POSTGRADUATE STUDIES SPORTS & EXERCISE MEDICINE DENTISTRY RADIOLOGY

1. Job Description Job Title: Executive Director, Irish Institute of Pharmacy Reporting to: RCSI CEO and will be a member of the Surgery and Post Graduate Faculties Board Please see Appendix A for overview of the reporting and governance structure Term of office: 4 Year Fixed Term Contract 1.1. Objective The objective of the post is to oversee the overall development and management of the CPD system in Ireland on behalf of PSI. The successful candidate will be responsible for the coordination of the development of the practice of pharmacy in line with international best practice and evolving healthcare needs. The Executive Director will have led and managed a unit/department or organisation with a significant staff base in the past. The Executive Director will have proven experience in Strategy development and operational delivery in a major, complex multi stakeholder environment (including accommodating multiple layers of accountability) is essential Of influencing senior levels in a relevant field Delivering significant change management programmes. Acting as Executive Director to the appointed Managing Body and ensuring its accountability for delivering on key milestones and targets in the establishment of a CPD system and development of pharmacy practice. Maintaining buy-in across all key stakeholder groups to the development and roll-out of the CPD system Developing a CPD portfolio system that facilitates reflection, recording and reporting on CPD engagement by pharmacists and meets the PSI's needs in terms of continued registration procedures Communicating requirements for engagement in CPD across the profession Maintaining systems and support to facilitate engagement in CPD by all pharmacists Overseeing a system of accreditation of CPD providers and provision to assure quality of activities Maintaining robust portfolio and practice review systems to assure the competency of pharmacists Working with the Director of Pharmacy Practice Development, identify and pursue opportunities around advancing the clinical practice of pharmacy and implementing recommendations of the Pharmacy 2020 review Developing and maintaining a programme of CPD activities that facilitates the maintenance and development of pharmacists' competencies in line with a defined competency framework and the identified needs of the profession and national policy direction. This programme must also reflect the requirements for evolved roles and services within the pharmacy profession. 1.2. Specific Accountabilities include: Providing leadership and direction in the delivery and development of the Irish Institute of Pharmacy Responsible for meeting the conditions of the Service Agreement with PSI Responsible for meeting the objectives and targets set by the CPD Institute Steering Group Responsible for developing the practice of pharmacy in line with international best practice and the required inputs in implementation of HSE Quality and Clinical Care Directorate programmes

Responsible for delivering responsibilities in marketing and stakeholder engagement in line with a wider marketing plan to underpin the development of the CPD system Responsible for delivering on relevant objectives set out in the PSI's Corporate Strategy and annual Service Plans. Responsible for overseeing a systematic approach to identification of continuing professional development needs of pharmacists working across all settings Responsible for establishing an approach to accreditation of CPD providers and provision that ensures quality and recognition of all CPD activities undertaken by pharmacists Responsible for establishing and maintaining an effective CPD portfolio system and practice review process Sufficient infrastructure to ensure that all pharmacists are supported in engagement in CPD with remediation systems in place where required. 1.3. Key Relationships: Must maintain engagement with all key stakeholders with an interest in the development of the profession and ensure ongoing trust, confidence and commitment from their respective cohorts Working closely and reporting to the PSI in meeting agreed objectives around development and delivery of CPD system and development of pharmacy practice Working closely with the HSE to facilitate and support the implementation of evidence-based, protocol driven, integrated clinical and therapeutic care, with a focus on optimising patient outcomes and meeting key safety, quality and cost effectiveness objectives Reporting to the Steering Group on delivery of Institute strategic plan and associated business and action plans Direct employee of the Managing Body to ensure strong and accountable management and organisational structure underpins the delivery of the CPD system and development of pharmacy practice Line management of the Director of Pharmacy Practice Development to ensure delivery of the remit of this role. Strong relationship with the pharmacy profession, including pharmacists working in different settings, with the Director required to perform a leadership role in managing the profession through a period of significant change. 1.4. Reporting Structures: Responsible for putting in place reporting structures that will ensure the following functions are delivered: Identifying and meeting needs of policy makers pharmacists in different practice settings Development of pharmacy practice Support infrastructure. 1.5. Performance Measures and Financial Accountabilities Accountable for a budget in excess of 1M Delivery of agreed objectives, service levels, targets and KPIs Overall target for engagement in CPD by the profession Overall target for the development of the practice of pharmacy.

1.6. Person Specification: Essential Skills Experience in developing strategic and operational plans, and translating these into annual objectives targets and milestones for delivery. Expertise in commissioning and procurement processes Vision for development of the profession and ability to work at a strategic level Consultation and negotiation expertise Senior level drafting, briefing and communication skills. Key Competencies Leader with track record of delivery Managing and delivering change Providing purpose and direction Improving organisational performance Building constructive working relationships Engaging effectively with stakeholders High level communication skills. Knowledge Person of international reputation for extensive expertise in a relevant field, demonstrated through academic achievement or from standing as a result of previous roles, responsibilities and performance Expertise in CPD portfolio and practice review systems (desirable) While previous involvement in the pharmacy profession is not required, a broad understanding of the wider healthcare sector either in Ireland or internationally would be advantageous. Knowledge of CPD in an equivalent profession and its relationship to patient outcomes would also be advantageous. Qualifications The person would be expected to have gathered a significant post graduate qualification in a relevant discipline during the course of his/her career. 1.7. The Process: Interview and presentation Shortlisted candidates will be invited for a formal competence-based interview at our main campus in RCSI Dublin. Candidates invited for interview will be given the title of the presentation in advance. 1.8. Particulars of Post The post is for a fixed term of 4 years, which will be filled on a full-time basis. The appointee to the post reports to the RCSI CEO and will be a member of the Surgery and Post Graduate Faculties Board (Appendix A, Reporting Structure). The financial package must primarily be driven be securing the right person and putting in place a financial reward package that can ensure acceptance of the offer. The pay structure will be in line with that adopted within the Department of Health and also be directly linked to performance and achievement of delivery milestones in the development of the CPD system. Salary: 100k+ plus performance related bonus & pension Informal enquiries can be made through John Kelly, email: johnpkelly@rcsi.ie or on +353 (0)1 4025116.

2. Application Process: Current curriculum vitae/resume which should include: full name, address, telephone number and email address; Name, position, professional relationship to the candidate and telephone / email contact details of three referees; Details of education, professional training and qualifications; Employment history, including present position and details of relevant professional, consulting or industry experience; Please note that applications finish at 5.00 pm on the closing date. All applications should be submitted to: garybrady@rcsi.ie Closing Date for Applications: 27 th September 2013 *Shortlisted candidates must be available to attend first round interviews on the RCSI Campus week commencing 21st October 2013 3. About the Irish Institute of Pharmacy The Irish Institute of Pharmacy (the Institute) has been established by the Pharmaceutical Society of Ireland (PSI, the pharmacy regulator) to oversee the development and management of the continuing professional development (CPD) system for the pharmacy profession in Ireland. The Institute will be managed by the RCSI on behalf of the PSI following a public procurement process. The Institute will have two core leadership roles: The development of a CPD system for pharmacists in Ireland and ensuring its effective on-going operation; and The development of the practice of pharmacy in line with international best practice and evolving healthcare needs. 3.1. Role of the Institute As the commissioning body for CPD programmes for pharmacists, the Institute will be responsible for delivering on the strategic aims of both the PSI and the Department of Health (DoH) in relation to the professional development of pharmacists. The Institute will also have responsibility for performing needs assessment within the pharmacy profession and ensuring that the programmes delivered reflect those needs. The Institute will be an independent body; however the DoH, the Health Services Executive (HSE), the PSI and the pharmacy profession will be involved in the steering of the Institute through the governance arrangements that will be implemented. This will ensure that input received from all parties is integrated into the running of the Institute. Such involvement will assure the development of the profession in line with the needs of the pharmacist, the regulator and the health service. RCSI, as the managing body for the Institute, will be responsible for delivering the following services: Needs identification. The RCSI will ensure that the needs of pharmacists working in different settings and the needs of the wider healthcare system are identified and reflected in the CPD system. They will also ensure that the CPD system reflects needs in line with defined professional competency standards, with patient safety and efficient treatment at the core. The RCSI will also be responsible for ensuring the CPD system continues to meet the needs of pharmacists on an on-going basis and supports the wider development of the profession.

CPD Programme Development and Expansion. The RCSI will be responsible for the development of an initial programme of CPD activities to launch the system with a practical demonstration of the benefits that can be realised from engagement. The RCSI will also be expected to ensure that details of the initial programme are communicated to the profession and that participation is facilitated. The RCSI will be responsible for coordinating the expansion of the programme of CPD activities in line with evidence of need during the period of the contract. Establishment of Accreditation System. The RCSI will be required to establish a formal system of accreditation for CPD providers and CPD provision, using standards set by the PSI. This will involve working in partnership with the PSI to develop and map clear processes and systems to underpin the accreditation process (e.g. the application process, selection criteria, assessment process, awarding structure, etc.). Leadership and Engagement. The RCSI will provide a structure that works closely in support of the Institute Executive Director and the Steering Group to build strong relationships with key stakeholders with an interest in the development of the profession. The RCSI will also be required to establish and manage an intensive programme of engagement with the wider pharmacy profession. CPD Portfolio Infrastructure. The RCSI will be responsible for the development and maintenance of an appropriate CPD portfolio infrastructure to facilitate the recording and reporting of CPD by individual pharmacists and the recognition and validation of compliance with the requirements of the regulator. CPD Support Structures. The RCSI will be responsible for ensuring that adequate support structures and systems are in place to facilitate the engagement in CPD by pharmacists. A central resource in this regard will be the CPD website, for which the RCSI will be responsible for its development and maintenance. CPD Portfolio Review System. The RCSI will be responsible for putting in place a CPD portfolio review process that will validate engagement by pharmacists on an on-going basis. The portfolio review system will examine the development and maintenance of competencies in line with the core competency framework defined for the profession. In partnership with the PSI, the RCSI will be required to develop specifications for how CPD portfolios are reviewed and how the sample of pharmacists is selected for this review. The feedback process to individual pharmacists must also be designed and implemented. CPD Practice Review Process. In addition to the CPD portfolio review system, the RCSI will be required to establish a peer-developed practice review process which recreates patient facing scenarios to assess competency (akin to objective structured clinical assessments - OSCEs), along with other assessment methods. The RCSI must work with key stakeholders and support structures to ensure sufficient peer input into the design and delivery of the system and commitment to its undertaking. The RCSI must also put in place appropriate training mechanisms to allow peers to act as assessors during the process and must develop and test the process with a sample of pharmacists to identify issues and improvements prior to roll-out. The RCSI must also work with the PSI to agree and define the remedial process for pharmacists that do not demonstrate the defined competency standards and the process of referral when non-compliance with CPD requirements is evident (in line with the key principles agreed around continued registration). The RCSI must then communicate the launch of the practice review exercise to the profession, making clear the objectives and nature of the exercise, the role of peers in its development, benefits for the profession, basis for selection, expectations from participants and roll-out schedule. The first round of practice reviews should then be delivered in 2014 with a sample of the profession to be agreed with the PSI. Pharmacy Practice Development. The Institute will be expected to lead work on development of the practice of pharmacy in Ireland to support the more active involvement of pharmacists in the delivery of integrated, patientcentred, cost-effective health services. This will involve facilitation and support of the implementation of evidencebased, protocol-driven, integrated clinical and therapeutic care, with a focus on optimising patient outcomes and meeting key safety, quality and cost-effectiveness objectives.

3.2. Establishment of Services The Institute s services will be rolled out over a four year period. A CPD portfolio system will be established in the early stages to allow pharmacists to record and reflect on learning obtained and required. This will be introduced in tandem with an Institute website to serve as a central source of information on CPD for pharmacists. There will be an initial focus on establishing support structures to help pharmacists to engage with the CPD system and on ensuring that learning opportunities are put in place that reflect the needs of all pharmacists and national healthcare policy. In 2014 a competencybased Quality Assurance process that is based on the successful QA programme for pharmacists in Ontario, will be developed and piloted. This QA process will be peer led and developed and will underpin the continued development of the profession. Full roll-out of the system is anticipated in2016 3.3. The Benefits of the Irish Institute of Pharmacy For the individual pharmacist The Institute will facilitate the provision of a source of accessible learning, tailored to individual needs. This will include online courses accessible from the Institute s website. It will provide reflective tools which will allow pharmacists to consider their own competencies and target areas of improvement. The Institute will, in time, also facilitate formal recognition of professional development and be able to recognise specialist and applied competencies held by pharmacists, while supporting advanced roles such as the superintendent pharmacist and senior clinical roles. The award of Fellowships by the Institute is envisaged, with the CPD portfolio system allowing ongoing recognition of all learning pursued and competencies developed. The Institute will also provide a mechanism to put in place support structures to facilitate the engagement of all pharmacists with CPD and other mechanisms that will allow pharmacists to engage with peers to share ideas and learning. For the individual profession As an effective CPD system needs to be aligned with development objectives, part of the Institute s remit will be to advance the practice of pharmacy and ensure that it continues to maintain and build upon its position at the forefront of healthcare delivery. Developments in pharmacy practice will be enabled, supported and facilitated by having an Institute and a quality assured CPD system in place. The Institute will enhance the profile and reputation of pharmacy in Ireland and support the building of closer links with other healthcare professions and more effective and integrated healthcare delivery. It will also assure the competence of the entire profession and reinforce consistent standards of service across all pharmacists for all patients. For patients, the health service and the wider public The Institute will seek to assure the competence of pharmacists as frontline health professionals serving all members of the public. It will provide a platform for pharmacists to share ideas, information and learning and draw on international evidence to ensure that practice is continually improved across services. The Institute will promote collaboration across the various healthcare professions and will facilitate inter-professional learning in the interests of service improvements. The development of the profession will facilitate more accessible, cost-effective and integrated delivery of healthcare and will ensure that patient needs are met in the local environment in a more timely manner. Specialised and advanced services will become increasingly available from the local pharmacy and the Institute will help to ensure that provision responds to the emerging needs of the health system and the wider public. The focus of the Institute will be on improving patient outcomes and patient safety, by ensuring patient needs are the focus of developing practice.

3.4. Steering Group for the Institute A Steering Group has been established by the PSI involving a representative cross-section of stakeholders to oversee the management of the Institute. The Steering Group is responsible for the development, establishment and on-going operation of the Institute and to agree a strategic plan. The strategic plan will set out the objectives of the services to be provided by the Institute and identify key targets/milestones for the delivery of these services. It will also form the basis for annual business and action plans outlining the activities and budgets which will be required to be approved and monitored by the Steering Group. The Terms of Reference for the Steering Group were approved by the Council of the PSI in 2012 and can be accessed on the PSI website at http://thepsi.ie/libraries/education/iiopsteeringgrouptermsofref_march13_final Rev1_Council_260313.sflb.ashx. 4. Royal College of Surgeons in Ireland Established in 1784, the Royal College of Surgeons in Ireland (RCSI) is an independent, not-for-profit, health sciences institution with a unique international perspective from its headquarters in Dublin to its presence on three continents. Its original purpose was to train surgeons and set national standards for surgery in Ireland. Today RCSI has a wide portfolio of undergraduate and postgraduate academic and professional courses. Its undergraduate medical school is the largest in Ireland. In Dublin RCSI educates a substantial cohort of international students, alongside Irish and other EU students. To remain competitive in an international market by providing an internationally recognised and respected medical and health sciences qualifications and careers, RCSI continually invests in educational standards, innovation and facilities. 5. The Pharmaceutical Society of Ireland (PSI) The PSI (www.thepsi.ie) is an independent statutory body, established by the Pharmacy Act 2007. It is charged with, and is accountable for, the effective regulation of pharmacy services in Ireland, including responsibility for supervising compliance with the Act. It works in the public interest to protect the health and safety of the public by regulating the pharmacy profession and pharmacies. The 2007 Act replaced a number of old Acts and regulations dating back to 1875. The PSI regulates the professional practice of approximately 5,000 pharmacists, 500 pharmaceutical assistants and over 1,700 pharmacies. The PSI is governed by a 21 member Council, with a non-pharmacist majority, appointed by the Minister for Health. The primary role of the PSI Council is protection of the public through the effective regulation of the profession and practice of pharmacy. An executive staff member at the PSI offices in Dublin supports the work of the Council. The PSI, as the pharmacy regulator, acts to protect and promote the health, safety and well-being of patients and the public. 6. Appendix A Reporting Structure The outline governance structure for the IIoP is set out below in Figure 1. The Executive Director (ED) of the IIoP is responsible for the successful operation of the IIoP. The ED is responsible for reporting on behalf of the IIoP. The ED will report directly to the RCSI and will provide regular briefings to the PSI through the contractual arrangements with the RCSI. The ED will liaise with the Steering Group on the strategic agenda for the IIoP.

Figure 1 Outline governance structure for the IIoP PSI PSI Council RCSI RCSI Council The Registrar of the PSI Registrar CEO Surgery & Postgraduate Faculties Board IIoP RCSI Quality Enhancement Office (QEO) Steering group Executive Director IIoP Contractual relationship line Direct reporting line Non reporting (collaboration) line Explanation of the governance structure: ED - RCSI Reporting Line: The ED is to report directly to the RCSI CEO and will be a member of the Surgery and Post Graduate Faculties Board. The structure and frequency of this reporting line is to be agreed between the RCSI and the ED. The ED is to liaise with the RCSI Quality Office on issues pertinent to quality. This is not a direct reporting (line management) line, however the IIoP will have to comply with RCSI quality standards, and will be subject to RCSI quality reviews (cyclical every 4 years). The ED will be responsible to ensure quality standards of the IIoP are maintained. ED PSI Contractual Line: The ED is to provide regular briefings to the Registrar of the PSI through the arrangements set out in the PSI-RCSI Contract and in the ED s contract of employment with the RCSI. These will include at a minimum that the ED will brief the PSI on the progress on delivery of annual plan and that the ED will update the Registrar of the PSI formally on at least a quarterly basis. ED - Steering Group: The ED will meet with the Steering Group a minimum of four times per year. The Steering Group is to provide guidance and advice on the strategic direction of the IIoP. Additional meetings to be held between the ED and the Steering Group at the discretion of the ED in consultation with the Chair of the Steering Group. This is not a direct reporting (line management) line.